Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-12 Sale | 2024-08-14 7:01 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO | 777,014 | $6.0643 | $4,712,049 | 7,309,496 (Indirect Direct) | View |
2024-06-06 Sale | 2024-06-10 4:29 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 61,795 | $4.32 | $266,954 | 8,086,510 (Indirect Direct) | View |
2024-03-14 Sale | 2024-03-18 6:12 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 318,573 | $5.39 | $1,717,108 | 8,148,305 (Indirect Direct) | View |
2023-11-30 Sale | 2023-12-01 7:42 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 3,968 | $1.97 | $7,817 | 6,926,878 (Indirect Direct) | View |
2023-09-27 Sale | 2023-09-29 8:03 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 115,632 | $2.7 | $312,206 | 6,930,846 (Indirect Direct) | View |
2023-01-11 Sale | 2023-01-13 4:34 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 15,870 | $0.91 | $14,442 | 7,046,478 (Indirect Direct) | View |
2022-10-14 Purchase | 2022-10-14 5:41 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 50,000 | $0.645 | $32,250 | 5,097,986 (Indirect Direct) | View |
2022-10-13 Purchase | 2022-10-13 6:17 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 73,256 | $0.5582 | $40,891 | 5,047,986 (Indirect Direct) | View |
2022-10-12 Purchase | 2022-10-12 8:51 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 38,153 | $0.5227 | $19,943 | 4,974,730 (Indirect Direct) | View |
2021-09-13 Purchase | 2021-09-14 4:44 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 10,001 | $14.5 | $145,038 | 4,694,777 (Indirect Direct) | View |
2020-07-20 Sale | 2020-07-22 9:55 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $26.68 | $1,200,789 | 6,548,603 (Indirect Direct) | View |
2020-07-07 Sale | 2020-07-09 9:55 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $31.86 | $1,433,796 | 5,973,871 (Indirect Direct) | View |
2020-05-28 Sale | 2020-06-01 7:52 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 125,000 | $42.7 | $5,337,500 | 5,224,101 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-05 Gift | 2024-08-14 7:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO | 1,495,772 | $0 | 7,309,496 (Indirect) | View |
2023-12-21 Option Award | 2023-12-22 8:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,540,000 | $0 | 8,466,878 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:34 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,964,362 | $0 | 7,046,478 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:40 pm | N/A 2032-01-25 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 2,204,132 | $0 | 1,102,066 (Direct) | View |
2022-01-25 Option Award | 2022-01-27 6:32 pm | N/A 2032-01-25 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 234,616 | $0 | 234,616 (Direct) | View |
2022-01-07 Option Award | 2022-01-11 6:45 pm | N/A 2032-01-07 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 201,500 | $0 | 5,017,177 (Direct) | View |
2021-12-14 Option Award(A) | 2022-01-11 6:42 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 120,900 | $0 | 4,815,677 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 8:30 pm | N/A 2031-12-14 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 201,500 | $0 | 4,896,277 (Direct) | View |
Ownership | 2021-02-16 9:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 0 | $0 | 4,684,836 (Indirect) | View |
2020-10-02 Ownership | 2021-02-16 9:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 200,000 | $0 | 4,684,836 (Direct) | View |
2020-12-10 Option Award | 2020-12-14 9:44 pm | N/A 2030-12-10 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 256,850 | $0 | 256,850 (Direct) | View |
Ownership | 2020-11-13 6:16 pm | N/A N/A | 180 Life Sciences Corp. | ATNF | Shendelman Shoshana Director | 0 | $0 | 0 (Direct) | View |
2020-07-20 Exercise | 2020-07-22 9:55 pm | N/A 2028-03-07 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $0 | 6,548,603 (Direct) | View |
2020-07-20 Exercise | 2020-07-22 9:55 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $1.44 | 6,548,603 (Direct) | View |
2020-07-07 Exercise | 2020-07-09 9:55 pm | N/A 2028-03-07 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $0 | 5,973,871 (Direct) | View |
2020-07-07 Exercise | 2020-07-09 9:55 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 45,000 | $1.44 | 5,973,871 (Direct) | View |
2020-05-28 Exercise | 2020-06-01 7:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 27,624 | $1 | 5,224,101 (Direct) | View |
2020-05-28 Exercise | 2020-06-01 7:52 pm | N/A 2027-03-27 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 125,000 | $0 | 5,224,101 (Direct) | View |
2020-02-28 Gift | 2020-06-01 7:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,000,000 | $0 | 5,224,101 (Direct) | View |
2020-05-28 Exercise | 2020-06-01 7:52 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 97,376 | $1.44 | 5,224,101 (Direct) | View |
Ownership | 2020-02-14 08:15 am | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 0 | $0 | 4,884,776 (Indirect) | View |
2019-12-19 Ownership | 2020-02-14 08:15 am | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 301,377 | $0 | 4,884,776 (Direct) | View |
2019-12-16 Option Award | 2019-12-18 6:24 pm | N/A 2029-12-16 | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 232,317 | $0 | 232,317 (Direct) | View |